context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
We report reinsurance premiums as a reduction to premium revenue, while related reinsurance recoveries are reported as a reduction to medical care costs. In certain cases, we participate in state-run reinsurance programs for which no reinsurance premium is paid. Reinsurance premiums amounted to $ 11 million, $ 2 millio... | text | 28 | monetaryItemType | text: <entity> 28 </entity> <entity type> monetaryItemType </entity type> <context> We report reinsurance premiums as a reduction to premium revenue, while related reinsurance recoveries are reported as a reduction to medical care costs. In certain cases, we participate in state-run reinsurance programs for which no re... | us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments |
We report reinsurance premiums as a reduction to premium revenue, while related reinsurance recoveries are reported as a reduction to medical care costs. In certain cases, we participate in state-run reinsurance programs for which no reinsurance premium is paid. Reinsurance premiums amounted to $ 11 million, $ 2 millio... | text | 27 | monetaryItemType | text: <entity> 27 </entity> <entity type> monetaryItemType </entity type> <context> We report reinsurance premiums as a reduction to premium revenue, while related reinsurance recoveries are reported as a reduction to medical care costs. In certain cases, we participate in state-run reinsurance programs for which no re... | us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments |
In 2023, we closed on one business combination in the Medicaid and Medicare segments, consistent with our growth strategy. For this transaction, we applied the acquisition method of accounting, where the total purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed, based on ... | text | 4 | monetaryItemType | text: <entity> 4 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, we closed on one business combination in the Medicaid and Medicare segments, consistent with our growth strategy. For this transaction, we applied the acquisition method of accounting, where the total purchase price was allocate... | us-gaap:AcquisitionCosts |
On September 1, 2023, we closed on our acquisition of My Choice Wisconsin for preliminary purchase consideration of approximately $ 74 million. Finalization of purchase price adjustments, as provided in the definitive asset purchase agreement governing the transaction, is expected to occur in the first half of 2024. | text | 74 | monetaryItemType | text: <entity> 74 </entity> <entity type> monetaryItemType </entity type> <context> On September 1, 2023, we closed on our acquisition of My Choice Wisconsin for preliminary purchase consideration of approximately $ 74 million. Finalization of purchase price adjustments, as provided in the definitive asset purchase agr... | us-gaap:BusinessCombinationConsiderationTransferred1 |
Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Such assets include synergies we expect to achieve as a resul... | text | 95 | monetaryItemType | text: <entity> 95 </entity> <entity type> monetaryItemType </entity type> <context> Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and ... | us-gaap:Goodwill |
Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Such assets include synergies we expect to achieve as a resul... | text | 31 | monetaryItemType | text: <entity> 31 </entity> <entity type> monetaryItemType </entity type> <context> Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and ... | us-gaap:Goodwill |
The net changes in fair value of Level 3 financial instruments are reported in “Other” operating expenses in our consolidated statements of income. In the year ended December 31, 2022, we recognized a loss of $ 4 million, primarily for the increase in the fair value of the contingent consideration liability described b... | text | 4 | monetaryItemType | text: <entity> 4 </entity> <entity type> monetaryItemType </entity type> <context> The net changes in fair value of Level 3 financial instruments are reported in “Other” operating expenses in our consolidated statements of income. In the year ended December 31, 2022, we recognized a loss of $ 4 million, primarily for t... | us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings |
In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 million, and $ 381 million, respectively. Gross realized gains and losses from sales o... | text | 513 | monetaryItemType | text: <entity> 513 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 m... | us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities |
In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 million, and $ 381 million, respectively. Gross realized gains and losses from sales o... | text | 1069 | monetaryItemType | text: <entity> 1069 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 ... | us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities |
In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 million, and $ 381 million, respectively. Gross realized gains and losses from sales o... | text | 948 | monetaryItemType | text: <entity> 948 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 m... | us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities |
In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 million, and $ 381 million, respectively. Gross realized gains and losses from sales o... | text | 259 | monetaryItemType | text: <entity> 259 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 m... | us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt |
In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 million, and $ 381 million, respectively. Gross realized gains and losses from sales o... | text | 329 | monetaryItemType | text: <entity> 329 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 m... | us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt |
In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 million, and $ 381 million, respectively. Gross realized gains and losses from sales o... | text | 381 | monetaryItemType | text: <entity> 381 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 m... | us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt |
In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 million, and $ 381 million, respectively. Gross realized gains and losses from sales o... | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 mil... | us-gaap:DebtSecuritiesAvailableForSaleRealizedGain |
In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 million, and $ 381 million, respectively. Gross realized gains and losses from sales o... | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 mi... | us-gaap:DebtSecuritiesAvailableForSaleRealizedGain |
In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 million, and $ 381 million, respectively. Gross realized gains and losses from sales o... | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 mi... | us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss |
In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 million, and $ 381 million, respectively. Gross realized gains and losses from sales o... | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2023, 2022, and 2021, maturities and redemptions of available-for-sale securities amounted to $ 513 million, $ 1,069 million, and $ 948 million, respectively, and sales amounted to $ 259 million, $ 329 mil... | us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss |
We have the ability to hold these restricted investments until maturity, and as a result, we would not expect the value of these investments to decline significantly due to a sudden change in market interest rates. Our held-to-maturity restricted investments are carried at amortized cost, which approximates fair value,... | text | 190 | monetaryItemType | text: <entity> 190 </entity> <entity type> monetaryItemType </entity type> <context> We have the ability to hold these restricted investments until maturity, and as a result, we would not expect the value of these investments to decline significantly due to a sudden change in market interest rates. Our held-to-maturity... | us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount |
We have the ability to hold these restricted investments until maturity, and as a result, we would not expect the value of these investments to decline significantly due to a sudden change in market interest rates. Our held-to-maturity restricted investments are carried at amortized cost, which approximates fair value,... | text | 65 | monetaryItemType | text: <entity> 65 </entity> <entity type> monetaryItemType </entity type> <context> We have the ability to hold these restricted investments until maturity, and as a result, we would not expect the value of these investments to decline significantly due to a sudden change in market interest rates. Our held-to-maturity ... | us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount |
We have the ability to hold these restricted investments until maturity, and as a result, we would not expect the value of these investments to decline significantly due to a sudden change in market interest rates. Our held-to-maturity restricted investments are carried at amortized cost, which approximates fair value,... | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> We have the ability to hold these restricted investments until maturity, and as a result, we would not expect the value of these investments to decline significantly due to a sudden change in market interest rates. Our held-to-maturity r... | us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount |
The Company recognized an impairment on property and equipment of $ 16 million associated with our reduction in leased space used in our business operations in the year ended December 31, 2022. | text | 16 | monetaryItemType | text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized an impairment on property and equipment of $ 16 million associated with our reduction in leased space used in our business operations in the year ended December 31, 2022. </context> | us-gaap:TangibleAssetImpairmentCharges |
In the year ended December 31, 2022, the Company recognized $ 192 million of ROU asset impairments associated with our reduction in leased space used in our business operations to accommodate our move to a remote work environment. | text | 192 | monetaryItemType | text: <entity> 192 </entity> <entity type> monetaryItemType </entity type> <context> In the year ended December 31, 2022, the Company recognized $ 192 million of ROU asset impairments associated with our reduction in leased space used in our business operations to accommodate our move to a remote work environment. </co... | us-gaap:OperatingLeaseImpairmentLoss |
As of December 31, 2023, the weighted-average discount rate used to compute the present value of lease payments was 4.8 % for operating lease liabilities, and 6.4 % for finance lease liabilities. The components of lease expense for the years ended December 31, 2023, 2022, and 2021 are presented in the following table. | text | 4.8 | percentItemType | text: <entity> 4.8 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023, the weighted-average discount rate used to compute the present value of lease payments was 4.8 % for operating lease liabilities, and 6.4 % for finance lease liabilities. The components of lease expense for the ... | us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent |
As of December 31, 2023, the weighted-average discount rate used to compute the present value of lease payments was 4.8 % for operating lease liabilities, and 6.4 % for finance lease liabilities. The components of lease expense for the years ended December 31, 2023, 2022, and 2021 are presented in the following table. | text | 6.4 | percentItemType | text: <entity> 6.4 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023, the weighted-average discount rate used to compute the present value of lease payments was 4.8 % for operating lease liabilities, and 6.4 % for finance lease liabilities. The components of lease expense for the ... | us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent |
Our estimates of medical claims and benefits payable recorded at December 31, 2023, 2022 and 2021 developed favorably by approximately $ 427 million, $ 284 million and $ 239 million in 2023, 2022 and 2021, respectively. The favorable prior year development recognized in 2023 was primarily due to lower than expected uti... | text | 427 | monetaryItemType | text: <entity> 427 </entity> <entity type> monetaryItemType </entity type> <context> Our estimates of medical claims and benefits payable recorded at December 31, 2023, 2022 and 2021 developed favorably by approximately $ 427 million, $ 284 million and $ 239 million in 2023, 2022 and 2021, respectively. The favorable p... | us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense |
Our estimates of medical claims and benefits payable recorded at December 31, 2023, 2022 and 2021 developed favorably by approximately $ 427 million, $ 284 million and $ 239 million in 2023, 2022 and 2021, respectively. The favorable prior year development recognized in 2023 was primarily due to lower than expected uti... | text | 284 | monetaryItemType | text: <entity> 284 </entity> <entity type> monetaryItemType </entity type> <context> Our estimates of medical claims and benefits payable recorded at December 31, 2023, 2022 and 2021 developed favorably by approximately $ 427 million, $ 284 million and $ 239 million in 2023, 2022 and 2021, respectively. The favorable p... | us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense |
Our estimates of medical claims and benefits payable recorded at December 31, 2023, 2022 and 2021 developed favorably by approximately $ 427 million, $ 284 million and $ 239 million in 2023, 2022 and 2021, respectively. The favorable prior year development recognized in 2023 was primarily due to lower than expected uti... | text | 239 | monetaryItemType | text: <entity> 239 </entity> <entity type> monetaryItemType </entity type> <context> Our estimates of medical claims and benefits payable recorded at December 31, 2023, 2022 and 2021 developed favorably by approximately $ 427 million, $ 284 million and $ 239 million in 2023, 2022 and 2021, respectively. The favorable p... | us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense |
We are party to a credit agreement (the “Credit Agreement”) which includes a revolving credit facility (“Credit Facility”) of $ 1.0 billion, among other provisions. The Credit Agreement has a term of five years , and all amounts outstanding will be due and payable on June 8, 2025. Borrowings under the Credit Agreement ... | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> We are party to a credit agreement (the “Credit Agreement”) which includes a revolving credit facility (“Credit Facility”) of $ 1.0 billion, among other provisions. The Credit Agreement has a term of five years , and all amounts outsta... | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The Credit Agreement contains customary non-financial and financial covenants. As of December 31, 2023, we were in compliance with all financial and non-financial covenants under the Credit Agreement. As of December 31, 2023, no amounts were outstanding under the Credit Facility. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> The Credit Agreement contains customary non-financial and financial covenants. As of December 31, 2023, we were in compliance with all financial and non-financial covenants under the Credit Agreement. As of December 31, 2023, no amounts... | us-gaap:LineOfCredit |
4.375 % Notes due 2028. | text | 4.375 | percentItemType | text: <entity> 4.375 </entity> <entity type> percentItemType </entity type> <context> 4.375 % Notes due 2028. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
We have $ 800 million aggregate principal amount of senior notes (the “ 4.375 % Notes”) outstanding as of December 31, 2023, which are due June 15, 2028, unless earlier redeemed. Interest, at a rate of 4.375 % per annum, is payable semiannually in arrears on June 15 and December 15. | text | 800 | monetaryItemType | text: <entity> 800 </entity> <entity type> monetaryItemType </entity type> <context> We have $ 800 million aggregate principal amount of senior notes (the “ 4.375 % Notes”) outstanding as of December 31, 2023, which are due June 15, 2028, unless earlier redeemed. Interest, at a rate of 4.375 % per annum, is payable sem... | us-gaap:DebtInstrumentFaceAmount |
We have $ 800 million aggregate principal amount of senior notes (the “ 4.375 % Notes”) outstanding as of December 31, 2023, which are due June 15, 2028, unless earlier redeemed. Interest, at a rate of 4.375 % per annum, is payable semiannually in arrears on June 15 and December 15. | text | 4.375 | percentItemType | text: <entity> 4.375 </entity> <entity type> percentItemType </entity type> <context> We have $ 800 million aggregate principal amount of senior notes (the “ 4.375 % Notes”) outstanding as of December 31, 2023, which are due June 15, 2028, unless earlier redeemed. Interest, at a rate of 4.375 % per annum, is payable se... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
3.875 % Notes due 2030. | text | 3.875 | percentItemType | text: <entity> 3.875 </entity> <entity type> percentItemType </entity type> <context> 3.875 % Notes due 2030. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
We have $ 650 million aggregate principal amount of senior notes (the “ 3.875 % Notes due 2030”) outstanding as of December 31, 2023, which are due November 15, 2030, unless earlier redeemed. Interest, at a rate of 3.875 % per annum, is payable semiannually in arrears on May 15 and November 15. | text | 650 | monetaryItemType | text: <entity> 650 </entity> <entity type> monetaryItemType </entity type> <context> We have $ 650 million aggregate principal amount of senior notes (the “ 3.875 % Notes due 2030”) outstanding as of December 31, 2023, which are due November 15, 2030, unless earlier redeemed. Interest, at a rate of 3.875 % per annum, i... | us-gaap:DebtInstrumentFaceAmount |
We have $ 650 million aggregate principal amount of senior notes (the “ 3.875 % Notes due 2030”) outstanding as of December 31, 2023, which are due November 15, 2030, unless earlier redeemed. Interest, at a rate of 3.875 % per annum, is payable semiannually in arrears on May 15 and November 15. | text | 3.875 | percentItemType | text: <entity> 3.875 </entity> <entity type> percentItemType </entity type> <context> We have $ 650 million aggregate principal amount of senior notes (the “ 3.875 % Notes due 2030”) outstanding as of December 31, 2023, which are due November 15, 2030, unless earlier redeemed. Interest, at a rate of 3.875 % per annum, ... | us-gaap:DebtInstrumentInterestRateStatedPercentage |
3.875 % Notes due 2032. | text | 3.875 | percentItemType | text: <entity> 3.875 </entity> <entity type> percentItemType </entity type> <context> 3.875 % Notes due 2032. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
At December 31, 2023, we had state net operating loss carryforwards of $ 53 million, which begin expiring in 2036. | text | 53 | monetaryItemType | text: <entity> 53 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, we had state net operating loss carryforwards of $ 53 million, which begin expiring in 2036. </context> | us-gaap:OperatingLossCarryforwards |
At December 31, 2023, we had foreign net operating loss carryforwards of $ 11 million, which begin expiring in 2031. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, we had foreign net operating loss carryforwards of $ 11 million, which begin expiring in 2031. </context> | us-gaap:OperatingLossCarryforwards |
At December 31, 2023, we had foreign tax credit carryovers of $ 5 million, which expire in 2030. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, we had foreign tax credit carryovers of $ 5 million, which expire in 2030. </context> | us-gaap:TaxCreditCarryforwardAmount |
We evaluate the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary differences. We have determined that as of December 31, 2023, $ 24 million of deferred tax ass... | text | 24 | monetaryItemType | text: <entity> 24 </entity> <entity type> monetaryItemType </entity type> <context> We evaluate the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary difference... | us-gaap:TaxCreditCarryforwardValuationAllowance |
We evaluate the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary differences. We have determined that as of December 31, 2023, $ 24 million of deferred tax ass... | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> We evaluate the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary differences... | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
We evaluate the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary differences. We have determined that as of December 31, 2023, $ 24 million of deferred tax ass... | text | 18 | monetaryItemType | text: <entity> 18 </entity> <entity type> monetaryItemType </entity type> <context> We evaluate the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary difference... | us-gaap:DeferredTaxAssetsValuationAllowance |
We evaluate the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary differences. We have determined that as of December 31, 2023, $ 24 million of deferred tax ass... | text | 24 | monetaryItemType | text: <entity> 24 </entity> <entity type> monetaryItemType </entity type> <context> We evaluate the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary difference... | us-gaap:DeferredTaxAssetsValuationAllowance |
The total amount of unrecognized tax benefits at December 31, 2023, 2022 and 2021 that, if recognized, would affect the effective tax rates is $ 5 million, $ 5 million, and $ 15 million, respectively. We expect that during the next 12 months it is reasonably possible that unrecognized tax benefit liabilities may decrea... | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> The total amount of unrecognized tax benefits at December 31, 2023, 2022 and 2021 that, if recognized, would affect the effective tax rates is $ 5 million, $ 5 million, and $ 15 million, respectively. We expect that during the next 12 mo... | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The total amount of unrecognized tax benefits at December 31, 2023, 2022 and 2021 that, if recognized, would affect the effective tax rates is $ 5 million, $ 5 million, and $ 15 million, respectively. We expect that during the next 12 months it is reasonably possible that unrecognized tax benefit liabilities may decrea... | text | 15 | monetaryItemType | text: <entity> 15 </entity> <entity type> monetaryItemType </entity type> <context> The total amount of unrecognized tax benefits at December 31, 2023, 2022 and 2021 that, if recognized, would affect the effective tax rates is $ 5 million, $ 5 million, and $ 15 million, respectively. We expect that during the next 12 m... | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The total amount of unrecognized tax benefits at December 31, 2023, 2022 and 2021 that, if recognized, would affect the effective tax rates is $ 5 million, $ 5 million, and $ 15 million, respectively. We expect that during the next 12 months it is reasonably possible that unrecognized tax benefit liabilities may decrea... | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> The total amount of unrecognized tax benefits at December 31, 2023, 2022 and 2021 that, if recognized, would affect the effective tax rates is $ 5 million, $ 5 million, and $ 15 million, respectively. We expect that during the next 12 mo... | us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible |
In September 2023, our board of directors authorized the purchase of up to $ 750 million of our common stock. This new program supersedes the stock purchase program previously approved by our board of directors in November 2022 and extends through December 31, 2024. The exact timing and amount of any repurchase is dete... | text | 750 | monetaryItemType | text: <entity> 750 </entity> <entity type> monetaryItemType </entity type> <context> In September 2023, our board of directors authorized the purchase of up to $ 750 million of our common stock. This new program supersedes the stock purchase program previously approved by our board of directors in November 2022 and ext... | us-gaap:StockRepurchaseProgramAuthorizedAmount1 |
In connection with our employee stock plans, approximately 442,000 shares and 755,000 shares of common stock were issued, net of shares used to settle employees’ income tax obligations, during the years ended December 31, 2023, and 2022, respectively. Total share-based compensation expense is reported in “General and a... | text | 442000 | sharesItemType | text: <entity> 442000 </entity> <entity type> sharesItemType </entity type> <context> In connection with our employee stock plans, approximately 442,000 shares and 755,000 shares of common stock were issued, net of shares used to settle employees’ income tax obligations, during the years ended December 31, 2023, and 20... | us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation |
In connection with our employee stock plans, approximately 442,000 shares and 755,000 shares of common stock were issued, net of shares used to settle employees’ income tax obligations, during the years ended December 31, 2023, and 2022, respectively. Total share-based compensation expense is reported in “General and a... | text | 755000 | sharesItemType | text: <entity> 755000 </entity> <entity type> sharesItemType </entity type> <context> In connection with our employee stock plans, approximately 442,000 shares and 755,000 shares of common stock were issued, net of shares used to settle employees’ income tax obligations, during the years ended December 31, 2023, and 20... | us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation |
At December 31, 2023, we had employee equity incentives outstanding under our 2019 Equity Incentive Plan (the “2019 EIP”). The 2019 EIP provides for awards, in the form of restricted stock awards (“RSAs”), performance units (“PSUs”), stock options, and other stock– or cash–based awards, to eligible persons who perform ... | text | 2.9 | sharesItemType | text: <entity> 2.9 </entity> <entity type> sharesItemType </entity type> <context> At December 31, 2023, we had employee equity incentives outstanding under our 2019 Equity Incentive Plan (the “2019 EIP”). The 2019 EIP provides for awards, in the form of restricted stock awards (“RSAs”), performance units (“PSUs”), sto... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
. RSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. PSUs vest in their entirety at the end of three-year performance periods, if their performance condition... | text | 277.37 | perShareItemType | text: <entity> 277.37 </entity> <entity type> perShareItemType </entity type> <context> . RSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. PSUs vest in the... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
. RSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. PSUs vest in their entirety at the end of three-year performance periods, if their performance condition... | text | 312.27 | perShareItemType | text: <entity> 312.27 </entity> <entity type> perShareItemType </entity type> <context> . RSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. PSUs vest in the... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
. RSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. PSUs vest in their entirety at the end of three-year performance periods, if their performance condition... | text | 224.63 | perShareItemType | text: <entity> 224.63 </entity> <entity type> perShareItemType </entity type> <context> . RSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. PSUs vest in the... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
. RSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. PSUs vest in their entirety at the end of three-year performance periods, if their performance condition... | text | 233.50 | perShareItemType | text: <entity> 233.50 </entity> <entity type> perShareItemType </entity type> <context> . RSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. PSUs vest in the... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
. RSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. PSUs vest in their entirety at the end of three-year performance periods, if their performance condition... | text | 214.94 | perShareItemType | text: <entity> 214.94 </entity> <entity type> perShareItemType </entity type> <context> . RSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. PSUs vest in the... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
. RSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. PSUs vest in their entirety at the end of three-year performance periods, if their performance condition... | text | 74.52 | perShareItemType | text: <entity> 74.52 </entity> <entity type> perShareItemType </entity type> <context> . RSAs and PSUs are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. PSUs vest in thei... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
As of December 31, 2023, total unrecognized compensation expense related to unvested RSAs and PSUs was $ 88 million, and $ 52 million, respectively, which we expect to recognize over a remaining weighted-average period of 2.1 years, and 1.1 years, respectively. This unrecognized compensation cost assumes an estimated f... | text | 88 | monetaryItemType | text: <entity> 88 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, total unrecognized compensation expense related to unvested RSAs and PSUs was $ 88 million, and $ 52 million, respectively, which we expect to recognize over a remaining weighted-average period of 2.1 years, and... | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
As of December 31, 2023, total unrecognized compensation expense related to unvested RSAs and PSUs was $ 88 million, and $ 52 million, respectively, which we expect to recognize over a remaining weighted-average period of 2.1 years, and 1.1 years, respectively. This unrecognized compensation cost assumes an estimated f... | text | 52 | monetaryItemType | text: <entity> 52 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, total unrecognized compensation expense related to unvested RSAs and PSUs was $ 88 million, and $ 52 million, respectively, which we expect to recognize over a remaining weighted-average period of 2.1 years, and... | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
No stock options were granted in 2023, 2022, or 2021. As of December 31, 2023, there was no unrecognized compensation expense related to unvested stock options. | text | no | sharesItemType | text: <entity> no </entity> <entity type> sharesItemType </entity type> <context> No stock options were granted in 2023, 2022, or 2021. As of December 31, 2023, there was no unrecognized compensation expense related to unvested stock options. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares |
Under our ESPP, eligible employees may purchase common shares at 85 % of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a maximum purchase of $ 25,000 (as measured by the fair value of the stock acquired) p... | text | 0.1 | percentItemType | text: <entity> 0.1 </entity> <entity type> percentItemType </entity type> <context> Under our ESPP, eligible employees may purchase common shares at 85 % of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum |
Under our ESPP, eligible employees may purchase common shares at 85 % of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a maximum purchase of $ 25,000 (as measured by the fair value of the stock acquired) p... | text | 5.4 | percentItemType | text: <entity> 5.4 </entity> <entity type> percentItemType </entity type> <context> Under our ESPP, eligible employees may purchase common shares at 85 % of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a ... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum |
Under our ESPP, eligible employees may purchase common shares at 85 % of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a maximum purchase of $ 25,000 (as measured by the fair value of the stock acquired) p... | text | 28 | percentItemType | text: <entity> 28 </entity> <entity type> percentItemType </entity type> <context> Under our ESPP, eligible employees may purchase common shares at 85 % of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a m... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum |
Under our ESPP, eligible employees may purchase common shares at 85 % of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a maximum purchase of $ 25,000 (as measured by the fair value of the stock acquired) p... | text | 54 | percentItemType | text: <entity> 54 </entity> <entity type> percentItemType </entity type> <context> Under our ESPP, eligible employees may purchase common shares at 85 % of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a m... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum |
Under our ESPP, eligible employees may purchase common shares at 85 % of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a maximum purchase of $ 25,000 (as measured by the fair value of the stock acquired) p... | text | 0 | percentItemType | text: <entity> 0 </entity> <entity type> percentItemType </entity type> <context> Under our ESPP, eligible employees may purchase common shares at 85 % of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a ma... | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate |
We sponsor defined contribution 401(k) plans that cover substantially all employees of our company and its subsidiaries. Eligible employees are permitted to contribute up to the maximum amount allowed by law. We match up to the first 4 % of compensation contributed by employees. Expense recognized in connection with ou... | text | 4 | percentItemType | text: <entity> 4 </entity> <entity type> percentItemType </entity type> <context> We sponsor defined contribution 401(k) plans that cover substantially all employees of our company and its subsidiaries. Eligible employees are permitted to contribute up to the maximum amount allowed by law. We match up to the first 4 % ... | us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent |
We sponsor defined contribution 401(k) plans that cover substantially all employees of our company and its subsidiaries. Eligible employees are permitted to contribute up to the maximum amount allowed by law. We match up to the first 4 % of compensation contributed by employees. Expense recognized in connection with ou... | text | 54 | monetaryItemType | text: <entity> 54 </entity> <entity type> monetaryItemType </entity type> <context> We sponsor defined contribution 401(k) plans that cover substantially all employees of our company and its subsidiaries. Eligible employees are permitted to contribute up to the maximum amount allowed by law. We match up to the first 4 ... | us-gaap:DefinedContributionPlanCostRecognized |
We sponsor defined contribution 401(k) plans that cover substantially all employees of our company and its subsidiaries. Eligible employees are permitted to contribute up to the maximum amount allowed by law. We match up to the first 4 % of compensation contributed by employees. Expense recognized in connection with ou... | text | 45 | monetaryItemType | text: <entity> 45 </entity> <entity type> monetaryItemType </entity type> <context> We sponsor defined contribution 401(k) plans that cover substantially all employees of our company and its subsidiaries. Eligible employees are permitted to contribute up to the maximum amount allowed by law. We match up to the first 4 ... | us-gaap:DefinedContributionPlanCostRecognized |
We sponsor defined contribution 401(k) plans that cover substantially all employees of our company and its subsidiaries. Eligible employees are permitted to contribute up to the maximum amount allowed by law. We match up to the first 4 % of compensation contributed by employees. Expense recognized in connection with ou... | text | 41 | monetaryItemType | text: <entity> 41 </entity> <entity type> monetaryItemType </entity type> <context> We sponsor defined contribution 401(k) plans that cover substantially all employees of our company and its subsidiaries. Eligible employees are permitted to contribute up to the maximum amount allowed by law. We match up to the first 4 ... | us-gaap:DefinedContributionPlanCostRecognized |
We also have a non-qualified deferred compensation plan for certain key employees. Under this plan, eligible participants may defer portions of their base salary and bonus to provide tax-deferred growth. The deferrals are distributable based upon termination of employment or other periods, as elected under the plan and... | text | 39 | monetaryItemType | text: <entity> 39 </entity> <entity type> monetaryItemType </entity type> <context> We also have a non-qualified deferred compensation plan for certain key employees. Under this plan, eligible participants may defer portions of their base salary and bonus to provide tax-deferred growth. The deferrals are distributable ... | us-gaap:DeferredCompensationPlanAssets |
We also have a non-qualified deferred compensation plan for certain key employees. Under this plan, eligible participants may defer portions of their base salary and bonus to provide tax-deferred growth. The deferrals are distributable based upon termination of employment or other periods, as elected under the plan and... | text | 26 | monetaryItemType | text: <entity> 26 </entity> <entity type> monetaryItemType </entity type> <context> We also have a non-qualified deferred compensation plan for certain key employees. Under this plan, eligible participants may defer portions of their base salary and bonus to provide tax-deferred growth. The deferrals are distributable ... | us-gaap:DeferredCompensationPlanAssets |
All of our health plans except California, Florida, Massachusetts and New York, are subject to the RBC rules. The minimum statutory capital requirements in these states are based on a percentage of annualized premium revenue, a percentage of annualized health care costs, a percentage of certain liabilities, or other fi... | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> All of our health plans except California, Florida, Massachusetts and New York, are subject to the RBC rules. The minimum statutory capital requirements in these states are based on a percentage of annualized premium revenue, a percenta... | us-gaap:SpecialAssessmentBond |
Statutes, regulations and informal capital requirements also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to u... | text | 3.7 | monetaryItemType | text: <entity> 3.7 </entity> <entity type> monetaryItemType </entity type> <context> Statutes, regulations and informal capital requirements also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with ... | us-gaap:AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries |
Statutes, regulations and informal capital requirements also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to u... | text | 742 | monetaryItemType | text: <entity> 742 </entity> <entity type> monetaryItemType </entity type> <context> Statutes, regulations and informal capital requirements also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with ... | us-gaap:CashCashEquivalentsAndShortTermInvestments |
Statutes, regulations and informal capital requirements also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to u... | text | 375 | monetaryItemType | text: <entity> 375 </entity> <entity type> monetaryItemType </entity type> <context> Statutes, regulations and informal capital requirements also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with ... | us-gaap:CashCashEquivalentsAndShortTermInvestments |
As of December 31, 2023, our health plans had aggregate statutory capital and surplus of approximately $ 4.1 billion, which was in excess of the required minimum aggregate statutory capital and surplus of approximately $ 2.3 billion. We have the ability and commitment to provide additional capital to each of our health... | text | 4.1 | monetaryItemType | text: <entity> 4.1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, our health plans had aggregate statutory capital and surplus of approximately $ 4.1 billion, which was in excess of the required minimum aggregate statutory capital and surplus of approximately $ 2.3 billion. W... | us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance |
As of December 31, 2023, our health plans had aggregate statutory capital and surplus of approximately $ 4.1 billion, which was in excess of the required minimum aggregate statutory capital and surplus of approximately $ 2.3 billion. We have the ability and commitment to provide additional capital to each of our health... | text | 2.3 | monetaryItemType | text: <entity> 2.3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, our health plans had aggregate statutory capital and surplus of approximately $ 4.1 billion, which was in excess of the required minimum aggregate statutory capital and surplus of approximately $ 2.3 billion. W... | us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired |
We currently have four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. Our reportable segments are consistent with how we currently manage the business and view the markets we serve. | text | four | integerItemType | text: <entity> four </entity> <entity type> integerItemType </entity type> <context> We currently have four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. Our reportable segments are consistent with how we currently manage the business and view the markets we serve. </context... | us-gaap:NumberOfReportableSegments |
The Registrant provides certain centralized medical and administrative services to our subsidiaries pursuant to administrative services agreements that include, but are not limited to, information technology, product development and administration, underwriting, claims processing, customer service, certain care managem... | text | 2038 | monetaryItemType | text: <entity> 2038 </entity> <entity type> monetaryItemType </entity type> <context> The Registrant provides certain centralized medical and administrative services to our subsidiaries pursuant to administrative services agreements that include, but are not limited to, information technology, product development and a... | us-gaap:Revenues |
The Registrant provides certain centralized medical and administrative services to our subsidiaries pursuant to administrative services agreements that include, but are not limited to, information technology, product development and administration, underwriting, claims processing, customer service, certain care managem... | text | 1826 | monetaryItemType | text: <entity> 1826 </entity> <entity type> monetaryItemType </entity type> <context> The Registrant provides certain centralized medical and administrative services to our subsidiaries pursuant to administrative services agreements that include, but are not limited to, information technology, product development and a... | us-gaap:Revenues |
The Registrant provides certain centralized medical and administrative services to our subsidiaries pursuant to administrative services agreements that include, but are not limited to, information technology, product development and administration, underwriting, claims processing, customer service, certain care managem... | text | 1496 | monetaryItemType | text: <entity> 1496 </entity> <entity type> monetaryItemType </entity type> <context> The Registrant provides certain centralized medical and administrative services to our subsidiaries pursuant to administrative services agreements that include, but are not limited to, information technology, product development and a... | us-gaap:Revenues |
amount of the asset group exceeds its estimated undiscounted future cash flows, an impairment charge is recognized in the amount by which its carrying amount exceeds its fair value. We recorded $ 166 million of impairment charges related to our property, plant and equipment during the year ended December 31, 2024. No i... | text | 166 | monetaryItemType | text: <entity> 166 </entity> <entity type> monetaryItemType </entity type> <context> amount of the asset group exceeds its estimated undiscounted future cash flows, an impairment charge is recognized in the amount by which its carrying amount exceeds its fair value. We recorded $ 166 million of impairment charges relat... | us-gaap:ImpairmentOfLongLivedAssetsHeldForUse |
We have three reportable segments comprised of the 1) Americas, 2) EMEA and 3) Asia-Pacific geographic regions, which we also determined are our reporting units. Goodwill is not amortized and is tested for impairment at least annually or more often if and when circumstances indicate that goodwill is not recoverable. | text | three | integerItemType | text: <entity> three </entity> <entity type> integerItemType </entity type> <context> We have three reportable segments comprised of the 1) Americas, 2) EMEA and 3) Asia-Pacific geographic regions, which we also determined are our reporting units. Goodwill is not amortized and is tested for impairment at least annually... | us-gaap:NumberOfReportableSegments |
Generally, we assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Qualitative factors considered in the assessment include industry and market conditions, overall financial performance and other relevant events and factors a... | text | three | integerItemType | text: <entity> three </entity> <entity type> integerItemType </entity type> <context> Generally, we assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Qualitative factors considered in the assessment include industry and ma... | us-gaap:NumberOfReportingUnits |
group exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which its carrying amount exceeds its fair value. We recorded $ 29 million of impairment charges related to our finite-lived intangible assets during the year ended December 31, 2024. No impairment was record... | text | 29 | monetaryItemType | text: <entity> 29 </entity> <entity type> monetaryItemType </entity type> <context> group exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which its carrying amount exceeds its fair value. We recorded $ 29 million of impairment charges related to our finite-lived... | us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill |
The difference between the opening and closing balances of our accounts receivable, net, contract assets and deferred revenues primarily results from revenue growth and the timing difference between the satisfaction of our performance obligation and the customer's payment during the years ended December 31, 2024 and 20... | text | 88 | monetaryItemType | text: <entity> 88 </entity> <entity type> monetaryItemType </entity type> <context> The difference between the opening and closing balances of our accounts receivable, net, contract assets and deferred revenues primarily results from revenue growth and the timing difference between the satisfaction of our performance o... | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
The difference between the opening and closing balances of our accounts receivable, net, contract assets and deferred revenues primarily results from revenue growth and the timing difference between the satisfaction of our performance obligation and the customer's payment during the years ended December 31, 2024 and 20... | text | 95 | monetaryItemType | text: <entity> 95 </entity> <entity type> monetaryItemType </entity type> <context> The difference between the opening and closing balances of our accounts receivable, net, contract assets and deferred revenues primarily results from revenue growth and the timing difference between the satisfaction of our performance o... | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
The difference between the opening and closing balances of our accounts receivable, net, contract assets and deferred revenues primarily results from revenue growth and the timing difference between the satisfaction of our performance obligation and the customer's payment during the years ended December 31, 2024 and 20... | text | 83 | monetaryItemType | text: <entity> 83 </entity> <entity type> monetaryItemType </entity type> <context> The difference between the opening and closing balances of our accounts receivable, net, contract assets and deferred revenues primarily results from revenue growth and the timing difference between the satisfaction of our performance o... | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
The ending balances of net capitalized contract costs as of December 31, 2024 and 2023 were $ 436 million and $ 423 million, respectively, which were included in other assets in the consolidated balance sheet. $ 122 million, $ 103 | text | 436 | monetaryItemType | text: <entity> 436 </entity> <entity type> monetaryItemType </entity type> <context> The ending balances of net capitalized contract costs as of December 31, 2024 and 2023 were $ 436 million and $ 423 million, respectively, which were included in other assets in the consolidated balance sheet. $ 122 million, $ 103 </co... | us-gaap:CapitalizedContractCostNet |
The ending balances of net capitalized contract costs as of December 31, 2024 and 2023 were $ 436 million and $ 423 million, respectively, which were included in other assets in the consolidated balance sheet. $ 122 million, $ 103 | text | 423 | monetaryItemType | text: <entity> 423 </entity> <entity type> monetaryItemType </entity type> <context> The ending balances of net capitalized contract costs as of December 31, 2024 and 2023 were $ 436 million and $ 423 million, respectively, which were included in other assets in the consolidated balance sheet. $ 122 million, $ 103 </co... | us-gaap:CapitalizedContractCostNet |
The ending balances of net capitalized contract costs as of December 31, 2024 and 2023 were $ 436 million and $ 423 million, respectively, which were included in other assets in the consolidated balance sheet. $ 122 million, $ 103 | text | 122 | monetaryItemType | text: <entity> 122 </entity> <entity type> monetaryItemType </entity type> <context> The ending balances of net capitalized contract costs as of December 31, 2024 and 2023 were $ 436 million and $ 423 million, respectively, which were included in other assets in the consolidated balance sheet. $ 122 million, $ 103 </co... | us-gaap:CapitalizedContractCostAmortization |
The ending balances of net capitalized contract costs as of December 31, 2024 and 2023 were $ 436 million and $ 423 million, respectively, which were included in other assets in the consolidated balance sheet. $ 122 million, $ 103 | text | 103 | monetaryItemType | text: <entity> 103 </entity> <entity type> monetaryItemType </entity type> <context> The ending balances of net capitalized contract costs as of December 31, 2024 and 2023 were $ 436 million and $ 423 million, respectively, which were included in other assets in the consolidated balance sheet. $ 122 million, $ 103 </co... | us-gaap:CapitalizedContractCostAmortization |
million, and $ 96 million of contract costs were amortized during years ended December 31, 2024, 2023 and 2022, respectively, which were included in sales and marketing expense in the consolidated statement of operations. | text | 96 | monetaryItemType | text: <entity> 96 </entity> <entity type> monetaryItemType </entity type> <context> million, and $ 96 million of contract costs were amortized during years ended December 31, 2024, 2023 and 2022, respectively, which were included in sales and marketing expense in the consolidated statement of operations. </context> | us-gaap:CapitalizedContractCostAmortization |
As of December 31, 2024, approximately $ 11.0 billion of total revenues, including deferred installation revenues, are expected to be recognized in future periods. Most of our revenue contracts have an initial term varying from one to five years , and thereafter, automatically renew in one-year increments. Included in ... | text | 11.0 | monetaryItemType | text: <entity> 11.0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, approximately $ 11.0 billion of total revenues, including deferred installation revenues, are expected to be recognized in future periods. Most of our revenue contracts have an initial term varying from one to... | us-gaap:RevenueRemainingPerformanceObligation |
As of December 31, 2024, approximately $ 11.0 billion of total revenues, including deferred installation revenues, are expected to be recognized in future periods. Most of our revenue contracts have an initial term varying from one to five years , and thereafter, automatically renew in one-year increments. Included in ... | text | 70 | percentItemType | text: <entity> 70 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2024, approximately $ 11.0 billion of total revenues, including deferred installation revenues, are expected to be recognized in future periods. Most of our revenue contracts have an initial term varying from one to fi... | us-gaap:RevenueRemainingPerformanceObligationPercentage |
On July 20, 2024, we entered into an agreement to acquire three data centers in the Philippines from Total Information Management (“TIM”), a leading technology solutions provider in the market, for a stated purchase price of $ 180 million subject to certain adjustments. The acquisition is expected to close in the first... | text | 180 | monetaryItemType | text: <entity> 180 </entity> <entity type> monetaryItemType </entity type> <context> On July 20, 2024, we entered into an agreement to acquire three data centers in the Philippines from Total Information Management (“TIM”), a leading technology solutions provider in the market, for a stated purchase price of $ 180 mill... | us-gaap:BusinessCombinationConsiderationTransferred1 |
On May 2, 2022, we further expanded in Latin America through an acquisition of four data centers in Chile from Entel, a leading Chilean telecommunications provider, for a total purchase consideration of $ 638 million at the exchange rate in effect on that date. On August 1, 2022, we completed the acquisition of a data ... | text | 638 | monetaryItemType | text: <entity> 638 </entity> <entity type> monetaryItemType </entity type> <context> On May 2, 2022, we further expanded in Latin America through an acquisition of four data centers in Chile from Entel, a leading Chilean telecommunications provider, for a total purchase consideration of $ 638 million at the exchange ra... | us-gaap:BusinessCombinationConsiderationTransferred1 |
On May 2, 2022, we further expanded in Latin America through an acquisition of four data centers in Chile from Entel, a leading Chilean telecommunications provider, for a total purchase consideration of $ 638 million at the exchange rate in effect on that date. On August 1, 2022, we completed the acquisition of a data ... | text | 80 | monetaryItemType | text: <entity> 80 </entity> <entity type> monetaryItemType </entity type> <context> On May 2, 2022, we further expanded in Latin America through an acquisition of four data centers in Chile from Entel, a leading Chilean telecommunications provider, for a total purchase consideration of $ 638 million at the exchange rat... | us-gaap:BusinessCombinationConsiderationTransferred1 |
On April 1, 2022, we completed the acquisition of all outstanding shares of MainOne, which consisted of four data centers as well as a subsea cable and terrestrial fiber network. We acquired MainOne and its assets for a total purchase consideration of $ 278 million. The MainOne Acquisition supports our ongoing expansio... | text | 278 | monetaryItemType | text: <entity> 278 </entity> <entity type> monetaryItemType </entity type> <context> On April 1, 2022, we completed the acquisition of all outstanding shares of MainOne, which consisted of four data centers as well as a subsea cable and terrestrial fiber network. We acquired MainOne and its assets for a total purchase ... | us-gaap:BusinessCombinationConsiderationTransferred1 |
For the MainOne Acquisition, other current liabilities includes $ 10 million of deferred revenue, current and deferred tax and other liabilities includes $ 95 million of deferred revenue, non-current. | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> For the MainOne Acquisition, other current liabilities includes $ 10 million of deferred revenue, current and deferred tax and other liabilities includes $ 95 million of deferred revenue, non-current. </context> | us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue |
The operating results of the Entel Peru and Entel Chile acquisitions are reported in the Americas region and the operating results of the MainOne Acquisition are reported in the EMEA region following the date of acquisition. During the year of acquisition, our results of operations from these acquisitions included $ 90... | text | 90 | monetaryItemType | text: <entity> 90 </entity> <entity type> monetaryItemType </entity type> <context> The operating results of the Entel Peru and Entel Chile acquisitions are reported in the Americas region and the operating results of the MainOne Acquisition are reported in the EMEA region following the date of acquisition. During the ... | us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.